News

PortrAIt: Artificial intelligence for cancer diagnosis and therapy

Launched on March 31st in Villejuif, PortrAIt is a consortium resulting from the collaboration between Gustave Roussy and the start-up Owkin, incorporating key players in oncology. Its goal is to develop and deploy nationally around fifteen artificial intelligence tools in digital pathology to improve cancer management. This project aims to make France a global leader in personalized medicine based on artificial intelligence in the next five years.

Published on

PortrAIt

Launched on March 31st in Villejuif, PortrAIt is a consortium resulting from the collaboration between Gustave Roussy and the start-up Owkin, incorporating key players in oncology. Its goal is to develop and deploy nationally around fifteen artificial intelligence tools in digital pathology to improve cancer management. This project aims to make France a global leader in personalized medicine based on artificial intelligence in the next five years.

PortrAIt

Financed by the France 2030 investment plan and implemented by the agency Bpifrance, PortrAIt is a new consortium bringing together Gustave Roussy and Owkin, the Leon Berard cancer center, the French digital imaging company Tribun Health, the French pathological diagnosis company Cypath, and the National Federation of French Cancer Centers (Unicancer).

Structuring and organizing innovative artificial intelligence solutions

This ambitious project is based on the creation of 15 artificial intelligence tools for digital pathology diagnosis and therapy. The formation of machine learning models (deep learning) should allow the analysis of data from digital pathology slides (digitized images of patient tissue samples) for the development of more effective and accessible diagnostic tools, thus helping oncologists to personalize treatments at an earlier stage of the disease. PortrAIt will also accelerate the work of pathologists to detect the presence of certain biomarkers or predict patient outcomes. All these digital tools will be brought together on an evolving and interoperable digital platform that offers a research and collaboration framework for PortrAIt partners to be tested and deployed in French cancer centers and laboratoriesIn 2019, a framework agreement for research partnership and long-term collaboration was signed between Gustave Roussy and Owkin. This led to the development of RelaspRisk BC, the first prognostic artificial intelligence solution based on digital pathology, which predicts the risk of relapse in patients with localized breast cancer to avoid unnecessary chemotherapy after surgery.

 

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin